Poland - Generics on the offensive: Poland as the new arena for PI battles (rivaroxaban, apixaban, dapagliflozin, and more) | Kisaco Research

Poland - Generics on the offensive: Poland as the new arena for PI battles (rivaroxaban, apixaban, dapagliflozin, and more)

Speaker(s): 

Author:

Mariusz Kondrat

Managing Partner
Kondrat & Partners
... read more

Mariusz Kondrat

Managing Partner
Kondrat & Partners

Author:

Dawid Sierzant

Partner
SDP Sierzant Dudzinski
... read more

Dawid Sierzant

Partner
SDP Sierzant Dudzinski

Author:

Chris Dudzinski PhD

Partner
SDP Sierzant Dudzinski
... read more

Chris Dudzinski PhD

Partner
SDP Sierzant Dudzinski
Agenda Track No.: 
Track 1